Emerging treatments

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Beleid bij acute hypoglykemie met verminderd bewustzijnPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2022La prise en charge de l’hypoglycémie aiguë chez un patient présentant une diminution de la consciencePublished by: Groupe de Travail Développement de recommmandations de première ligneLast published: 2022

Verapamil

May inhibit insulin secretion at high doses, but evidence to support use in hypoglycaemia is limited.

Phenytoin

May inhibit insulin secretion at high doses, but evidence to support use in hypoglycaemia is limited.

Corticosteroids

In non-operable insulin-like growth factor-II-secreting tumours, there are case reports of successful control of hypoglycaemic symptoms by using an oral glucocorticoid.[55]

Use of this content is subject to our disclaimer